2015-2019 Growth Strategies in the French Coagulation Testing Market for Instrument and Reagent Suppliers

July 2015 | 405 pages | ID: 2AE40BD0466EN
Venture Planning Group

Abstracts

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 405 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib. , Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

Extensive strategic profiles ofmajor suppliers and emerging market entrants.

Market Segmentation Analysis

Comprehensive marketsegmentation analysis, including:- Hospitals

Commercial/Private Laboratories

Test volume forecasts for over 40 major proceduresby market segment.

Current and Emerging Products- Review of established and emerging procedures. - Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers. Technology Review- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations- Product development and business expansion opportunities with significant market appeal. - Ideal product models with tentativeprices and operating characteristics. - Alternative market penetrationstrategies for instrument and reagent suppliers. - Potential market entry barriers and risks. Contains 405 pages and 35 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. INTRODUCTION
  2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  3. ALPHA-2 ANTIPLASMIN
  4. ANTITHROMBIN III
  5. BLEEDING TIME
  6. D-DIMER
  7. ETHANOL FLOCCULATION TEST
  8. EUGLOBULIN LYSIS
  9. FACTOR ASSAYS
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. FIBRIN DEGRADATION PRODUCTS
  11. FIBRINOGEN
  12. HEPARIN
  13. HIRUDIN
  14. HYPERCOAGULABILITY AND THROMBOSIS
  15. LIPOPROTEIN A
  16. PLASMIN
  17. PLASMINOGEN
  18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
  19. PLATELET FUNCTION TESTS
  20. PLATELET AGGREGATION
  21. PROTEINS C AND S
  22. PROTHROMBIN FRAGMENT 1.2
  23. PROTHROMBIN TIME (PT)
  24. REPTILASE TIME
  25. THROMBIN TIME
  26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
  27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. CHROMOGENIC SUBSTRATES
  2. MONOCLONAL AND POLYCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. MOLECULAR DIAGNOSTICS
  5. MICROCOMPUTERS
  6. AUTOMATION
  7. ROBOTICS
  8. ARTIFICIAL INTELLIGENCE
  9. DRY CHEMISTRY
  10. BIOSENSORS

III. FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares

X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XII. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIV. COMPETITIVE ASSESSMENTS

Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: France, Total Coagulation Diagnostics Market By Market Segment and Product Category
France, Laboratories Performing Coagulation Tests By Market Segment
France, Hospital Laboratories Performing Coagulation Tests By Bed Size
France, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
France, Hospital Laboratories Average Daily Test Volume
France, Commercial/Private Laboratories Average Daily Test Volume
France, Total Coagulation Test Volume By Market Segment
France, All Market Segments Coagulation Test Volume
France, Hospital Laboratories Coagulation Test Volume
France, Commercial/Private Laboratories Coagulation Test Volume
France, Coagulation Reagent Market By Market Segment
France, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
France, Coagulation Instrument Market By Market Segment
France, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
France, Total Coagulation Diagnostics Market By Product Category
France, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares